The Enterprise Value as of December 2025 (TTM) for Altamira Therapeutics Ltd. (EARS) is 383.82K

According to Altamira Therapeutics Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 383.82K. This represents a change of -88.09% compared to the average of 3.22M of the last 4 quarters.

Altamira Therapeutics Ltd. (EARS) Historical Enterprise Value (quarterly & annually)

How has EARS Enterprise Value performed in the past?

The mean historical Enterprise Value of Altamira Therapeutics Ltd. over the last ten years is 57.99M. The current 383.82K Enterprise Value has changed -33.81% with respect to the historical average. Over the past ten years (40 quarters), EARS's Enterprise Value was at its highest in in the December 2015 quarter at 279.17M. The Enterprise Value was at its lowest in in the March 2019 quarter at -5791929.00.

Altamira Therapeutics Ltd. (EARS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Altamira Therapeutics Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Altamira Therapeutics Ltd. (EARS) Average Enterprise Value

How has EARS Enterprise Value performed in the past?

The current Enterprise Value of Altamira Therapeutics Ltd. (EARS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Altamira Therapeutics Ltd. (EARS) Enterprise Value vs. Peers

How is EARS’s Enterprise Value compared to its peers?

Altamira Therapeutics Ltd.’s Enterprise Value is less than Hillstream BioPharma, Inc. (1.93M), less than TNF Pharmaceuticals, Inc. (8.98M), less than Gamida Cell Ltd. (40.73M), less than Aptose Biosciences Inc. (4.06M), less than AzurRx BioPharma, Inc. (1.75M), greater than Nabriva Therapeutics plc (-7192677.00), less than Gritstone bio, Inc. (43.29M), greater than VivoSim Labs, Inc. (-2756280.00), less than Atreca, Inc. (36.62M), greater than Neuphoria Therapeutics Inc. (-6013116.00),

Build a custom stock screener for Altamira Therapeutics Ltd. (EARS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Altamira Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Altamira Therapeutics Ltd. (EARS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Altamira Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.